Hotchkis & Wiley Capital Management LLC Sells 35,400 Shares of Select Medical Holdings Co. (NYSE:SEM)

Hotchkis & Wiley Capital Management LLC trimmed its position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 12.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 245,170 shares of the health services provider's stock after selling 35,400 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned 0.19% of Select Medical worth $8,549,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Hexagon Capital Partners LLC raised its position in Select Medical by 528.7% in the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider's stock worth $27,000 after acquiring an additional 645 shares during the period. Transcendent Capital Group LLC bought a new position in Select Medical in the 2nd quarter worth $35,000. Canada Pension Plan Investment Board purchased a new position in Select Medical during the second quarter valued at $39,000. DekaBank Deutsche Girozentrale bought a new stake in Select Medical during the second quarter valued at about $60,000. Finally, GAMMA Investing LLC raised its stake in shares of Select Medical by 52.8% in the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider's stock worth $70,000 after buying an additional 685 shares during the period. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SEM has been the subject of several analyst reports. Bank of America assumed coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a "buy" rating and a $42.00 target price for the company. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Tuesday. Benchmark downgraded shares of Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. Finally, Royal Bank of Canada raised their price target on Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a report on Monday, November 4th.

Select Medical Price Performance

Shares of NYSE:SEM traded down $0.07 during midday trading on Thursday, reaching $20.45. 1,654,049 shares of the company were exchanged, compared to its average volume of 668,844. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.65 billion, a PE ratio of 9.59, a price-to-earnings-growth ratio of 0.41 and a beta of 1.43. The business's fifty day moving average is $33.24 and its two-hundred day moving average is $34.43. Select Medical Holdings Co. has a one year low of $19.82 and a one year high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the business posted $0.46 earnings per share. The business's quarterly revenue was up 5.7% compared to the same quarter last year. As a group, analysts predict that Select Medical Holdings Co. will post 1.97 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.44%. Select Medical's dividend payout ratio is currently 23.36%.

Insider Buying and Selling

In related news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 19.14% of the stock is currently owned by company insiders.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.